U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing growing worry that Americans who got the single-dose shot aren’t as protected as those given two-dose brands.
Vaccine advisors are set to discuss mixing and matching COVID-19 vaccines Friday.
With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn.
Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans.
Johnson & Johnson is pushing for a booster shot of its vaccine, saying a second dose shows stronger protection. This comes as Pfizer prepares to apply for emergency use authorization for its vaccine in kids ages 5-11.
Johnson & Johnson said Tuesday that a booster of its one-shot coronavirus vaccine provides a stronger immune response months after people receive a first dose.
White House officials have also announced a plan to offer a booster shots to fully vaccinated Americans who got the Pfizer or Moderna vaccine. They are citing new evidence of waning vaccine protection over time, but where does that leave the Johnson & Johnson vaccine when it comes to boosters?
Consumer News: Amazon being sued over potentially unsafe products, Americans facing long waits to get a Passport and more.
Johnson & Johnson said Wednesday that it is recalling five of its sunscreen products after some samples were found to contain low levels of benzene, a chemical that can cause cancer with repeated exposure.
The FDA issued a new warning about the Johnson & Johnson vaccine, saying it could be linked to a rare neurological disorder.
